Sector : Pharmaceuticals
BSE
639.60 -0.64%
NSE
639.15 -0.58 %
Apr 12, 13:13
Glenmark Pharmaceuticals Q4 PAT seen up 30% YoY to Rs. 196.4 cr: Prabhudas Lilladher
Mar 18, 14:24
Mar 08, 14:46
Mar 06, 10:45
Glenmark Pharma appoints Alessandro Riva as CEO of its new innovation company in US
Apr 18, 16:00
Price
BSE
639.60 -0.64%
NSE
639.15 -0.58%
Share Target
Target(Rs)
Tip Period
Stop Loss
Your permanent Nickname can be distinct from your username and no one need know the link between the two.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
